RO7033877
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for RO7033877, covering 2016-11-02 to 2016-11-02. Get the full timeline:
Most recent: Clinical Trial Update: A Two-part, Single-dose, Randomized Study to Evaluate the Safety of Supra-therapeutic Doses of RO7033877 and to Investigate the Effect of RO7033877 on the QTc Interval [Phase 1]